0001306830-13-000044 8-K 29 20130418 2.02 7.01 9.01 20130418 20130418 Celanese Corp 0001306830 2820 980420726 DE 1231 8-K 34 001-32410 13769880 222 W. LAS COLINAS BLVD., SUITE 900N IRVING TX 75039-5421 972-443-4000 222 W. LAS COLINAS BLVD., SUITE 900N IRVING TX 75039-5421 Celanese CORP 20041102 Blackstone Crystal Holdings Capital Partners (Cayman) IV Ltd. 20041022 8-K 1 q120138-kdoc.htm 8-K Q1 2013 8-K DOC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 18, 2013 CELANESE CORPORATION (Exact name of registrant as specified in its charter) DELAWARE 001-32410 98-0420726 (State or other jurisdiction (Commission File (IRS Employer of incorporation) Number) Identification No.) 222 West Las Colinas Blvd. Suite 900N, Irving, TX 75039 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code: (972) 443-4000 (Former name or former address, if changed since last report): Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 1 -------------------------------------------------------------------------------- Item 2.02 Results of Operations and Financial Condition On April 18, 2013, Celanese Corporation (the “Company”) issued a press release reporting the financial results for its first quarter 2013. A copy of the press release is attached to this Current Report on Form 8-K (“Current Report”) as Exhibit 99.1 and is incorporated herein solely for purposes of this Item 2.02 disclosure. Item 7.01 Regulation FD Disclosure On April 19, 2013, Mark C. Rohr, Chairman and Chief Executive Officer of the Company, and Steven M. Sterin, Senior Vice President and Chief Financial Officer of the Company, will make a presentation to investors and analysts via a webcast hosted by the Company at 10:00 a.m. ET (9:00 a.m. CT). The webcast, prepared remarks from Mark Rohr and Steven Sterin and a slide presentation may be accessed on our website at www.celanese.com under Investor Events & Presentations. A copy of the slide presentation and a copy of the prepared remarks posted for the webcast are attached to this Current Report as Exhibit 99.2 and Exhibit 99.3, respectively, and are incorporated herein solely for purposes of this Item 7.01 disclosure. Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit Number Description 99.1 Press Release dated April 18, 2013* 99.2 Slide Presentation dated April 18, 2013* 99.3 Prepared Remarks from M. Rohr and S. Sterin dated April 18, 2013* *In connection with the disclosure set forth in Item 2.02 and Item 7.01, the information in this Current Report, including the exhibits attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in this Current Report, including the exhibits, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD. 2 -------------------------------------------------------------------------------- SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CELANESE CORPORATION By: /s/ James R. Peacock III Name: James R. Peacock III Title: Vice President, Deputy General Counsel and Assistant Corporate Secretary Date: April 18, 2013 INDEX TO EXHIBITS Exhibit Number Description 99.1 Press Release dated April 18, 2013* 99.2 Slide Presentation dated April 18, 2013* 99.3 Prepared Remarks from M. Rohr and S. Sterin dated April 18, 2013* * In connection with the disclosure set forth in Item 2.02 and Item 7.01, the information in this Current Report, including the exhibits attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in this Current Report, including the exhibits, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD. 3 EX-99.1 2 q120138-kex991.htm EX 99.1 - EARNINGS RELEASE Q1 2013 8-K EX99.1 Exhibit 99.1 [[Image Removed]] Celanese Corporation 222 West Las Colinas Blvd. Suite 900N Irving, Texas 75039 Celanese Corporation Reports First Quarter 2013 Results, Continue to Expect Adjusted Earnings Growth of 12 to 14 Percent for 2013 First quarter 2013 financial highlights: • GAAP operating profit of $184 million, up 66 percent over the prior year period • GAAP earnings per share of $0.88, down 27 percent from the prior year period due to GAAP taxes • Adjusted earnings per share of $1.14, up 44 percent over the prior year period • Adjusted EBIT of $269 million, up 37 percent over the prior year period • Adjusted EBIT margins of 16.8 percent, up 480 basis points over the prior year period • Adjusted EBIT increased year-over-year in Consumer Specialties, Advanced Engineered Materials and Acetyl Intermediates segments • Cash on hand increased to $978 million • Net debt decreased to less than $2.1 billion • Received quarterly dividend from China acetate ventures of $24 million Dallas, April 18, 2013: Celanese Corporation (NYSE: CE), a global technology and specialty materials company, today reported first quarter 2013 adjusted earnings per share of $1.14 versus $0.79 in the prior year quarter. Three Months Ended March 31, 2013 2012 As Adjusted (unaudited) (In $ millions, except per share data) Net sales 1,605 1,633 Operating profit (loss) 184 111 Net earnings (loss) 142 193 Adjusted EBIT (1) 269 196 Operating EBITDA (1) 345 268 Diluted EPS - continuing operations $ 0.88 $ 1.21 Diluted EPS - total $ 0.89 $ 1.21 Adjusted EPS (2) $ 1.14 $ 0.79 ______________________________ (1) Non-U.S. GAAP measure. See Table 1 for reconciliation. (2) Non-U.S. GAAP measure. See Table 3 for reconciliation. 1 -------------------------------------------------------------------------------- "Celanese delivered a strong quarter. We expanded adjusted EBIT margins both sequentially and year-over-year by more than 400 basis points as we continued to deliver value added solutions to our customers and began to see the impact of the Celanese-specific actions we are implementing. Our combined efforts helped us grow adjusted earnings per share by 44 percent over the prior year period," said Mark Rohr, chairman and chief executive officer. "Celanese continued to deliver good cash flow results in the first quarter and further increased the cash on our balance sheet. While we are off to a good start, our global teams must remain focused and continue to deliver improved results throughout the year for us to achieve our growth objectives." Recent Highlights • Signed a Memorandum of Understanding ("MOU") with Pertamina, the state-owned energy company of the Republic of Indonesia, to begin the detailed project planning phase for the development of fuel ethanol projects in Indonesia. The MOU outlines the parties' intentions to establish a joint venture under which Celanese would have a majority share and would license its leading TCXฎ Technology to the joint venture. Under the MOU, Celanese and Pertamina will select the first production location, initiate project permitting, and negotiate coal supply and other industrial partner agreements. Celanese and Pertamina expect to complete this phase of the MOU by the end of 2013. • Received the JEC Innovation Award for the first thermoplastic composite tailplane for a helicopter. The new composite tailplane of the Agusta Westland AW 169 helicopter results in 15 percent weight reduction from conventional composites and contributes considerably to fuel savings and lower emissions. • Introduced a new generation of Thermxฎ PCT grades that deliver outstanding initial reflectance and reflectance stability under heat and light as required in light-emitting diode ("LED") lighting packages found in display backlight and general lighting. • Elected Edward G. Galante to the company's board of directors. Galante is a former senior vice president, Exxon Mobil Corporation. • Changed the company's accounting policy for its defined benefit pension plans and other postretirement benefit plans (collectively, "Plans"). Under the new accounting policy, referred to as mark-to-market accounting, the company will recognize actuarial gains and losses and changes in the fair value of the Plans' assets in operating results in the fourth quarter of each year rather than deferring and amortizing them into future years. This change was effective January 1, 2013 and all amounts reported here reflect this new basis of accounting. First Quarter Business Segment Overview Advanced Engineered Materials Despite 9 percent lower year-over-year auto builds in Europe, Advanced Engineered Materials delivered $329 million of revenue, an all-time first quarter record, on continued success in global auto penetration and our innovation activities. The segment also increased first quarter adjusted EBIT by $8 million, or 11 percent over the prior year, and expanded adjusted EBIT margins to 23.7 percent on improved global product mix, mainly medical applications. Operating profit increased by $12 million over the prior year. 2 -------------------------------------------------------------------------------- Consumer Specialties Consumer Specialties increased first quarter adjusted EBIT by $50 million over the prior year period. $24 million of the increase in adjusted EBIT was due to a cash dividend from its China acetate ventures. Beginning this quarter, the company expects to receive quarterly dividends from these ventures rather than annual dividends. $26 million of the increase in adjusted EBIT was driven by continued strong demand in Acetate and lower energy costs related to the Spondon acetate facility that ceased production in the fourth quarter of 2012. Volumes increased 5 percent mainly due to an acetate production interruption in the first quarter of 2012 that did not recur in the first quarter of 2013. Operating profit increased by $38 million over the prior year. Industrial Specialties Adjusted EBIT in Industrial Specialties was $16 million in the first quarter compared with $22 million in the prior year as pricing decreased 4 percent on lower demand for photovoltaic applications in EVA (Ethylene Vinyl Acetate) and lower raw material costs, primarily ethylene, in Emulsions. First quarter volumes were 3 percent lower than the prior year primarily due to lower Emulsions demand in North America and Europe which was partially offset by stronger demand in Asia for VAE (Vinyl Acetate Ethylene) applications. Operating profit was $15 million in the first quarter compared with $20 million in the prior year. Acetyl Intermediates In the first quarter of 2013, global demand for acetyl products and their derivatives remained at low levels, resulting in 4 percent lower volumes and 1 percent lower pricing year-over-year. However, Acetyl Intermediates increased adjusted EBIT by $14 million, or 22 percent, and expanded adjusted EBIT margins to 9.8 percent on cost efficiencies and lower raw material costs. Operating profit increased by $13 million over the prior year. Capital Structure During the first three months of 2013, the company generated $147 million of operating cash flow in a seasonally challenging first quarter for working capital and ended the quarter with $978 million of cash on the balance sheet. Operating cash flow this quarter was $68 million lower than the prior year primarily due to the steepness of the global economic slowdown in early 2012 which resulted in temporarily lower working capital requirements in the first quarter of last year. Additionally, in the first quarter of last year the company received a one-time cash dividend from one of its Asian strategic affiliates. The company expects to have no required U.S. pension contributions in 2013 and has not changed its cash flow outlook for 2013. As of March 31, 2013, the company's net debt was $2.093 billion, a $46 million decrease from December 31, 2012 and the second lowest quarterly level for the company since March 31, 2005. While the company did not repurchase shares during the first quarter, it had a share repurchase authorization of $392 million as of March 31, 2013. The company will continue to repurchase shares to offset dilution from equity grants and when it believes the stock is valued attractively. Additionally, the company expects it will continue increasing its quarterly dividend payments. 3 -------------------------------------------------------------------------------- Strategic Affiliates Earnings from equity investments increased $3 million year-over-year to $54 million. Cash dividends received in the first quarter from equity investments was $47 million, $64 million lower than the prior year primarily due to a one-time cash dividend payment from one of the company's Asian strategic affiliates in the first quarter of 2012. During the first quarter of 2013, the company received its first quarterly dividend of $24 million from its China acetate ventures and now expects to receive quarterly dividends from these ventures rather than annual dividends that were paid in the second quarter of each year. Taxes The tax rate for adjusted earnings per share was 19 percent in the first quarter of 2013 and 17 percent in the first quarter of 2012. The effective tax rate for GAAP for the first quarter of 2013 was 35 percent compared to (61) percent in the first quarter of 2012. The effective income tax rate for GAAP for the first quarter of 2012 would have been 19 percent excluding the recognition of $142 million of foreign tax credit carryforwards. As compared to the first quarter of 2012, absent the effect of these events, the increase in the effective income tax rate for the first quarter of 2013 was primarily due to losses in jurisdictions without income tax benefit, increased earnings in high income tax jurisdictions and reassessment of the recoverability of deferred tax assets in certain jurisdictions. Net cash taxes paid were $14 million in the first quarter of 2013 compared with net cash taxes paid of $23 million in the first quarter of 2012. Outlook "We continue to expect adjusted earnings per share growth for 2013 will be consistent with our long-term growth objectives of 12 to 14 percent despite the higher 2012 earnings base after our pension accounting policy change and the challenging global economic environment that we anticipate to continue throughout 2013. Our global teams are diligently working on Celanese-specific initiatives as well as aligning our applications and technologies with our customer's priorities in order to deliver on our growth objectives," said Rohr. The company's earnings presentation and prepared remarks related to the first quarter results will be posted on its website at www.celanese.com in the investor section after market close on April 18. Contacts: Investor Relations Media - U.S. Media - Europe Jon Puckett Linda Beheler Jens Kurth Phone: +1 972 443 4965 Phone: +1 972 443 4924 Phone: +49(0)69 45009 1574 Telefax: +1 972 443 8519 Telefax: +1 972 443 8519 Telefax: +49(0) 45009 58800 Jon.Puckett@celanese.com Linda.Beheler@celanese.com J.Kurth@celanese.com Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. With sales almost equally divided between North America, Europe and Asia, the company uses the full breadth of its global chemistry, technology and business expertise to create value for customers and the corporation. Celanese partners with customers to solve their most critical needs while making a positive impact on its communities and the world. Based in Dallas, Texas, Celanese employs approximately 7,600 employees worldwide and had 2012 net sales of $6.4 billion. For more information about Celanese Corporation and its product offerings, visit www.celanese.com or our blog at www.celaneseblog.com 4 -------------------------------------------------------------------------------- Change in accounting policy regarding pension and other postretirement benefits Effective January 1, 2013, we elected to change our policy for recognizing actuarial gains and losses and the change in fair value of plan assets for our defined benefit pension plans and other postretirement benefit plans. We now immediately recognize the change in fair value of plan assets and net actuarial gains and losses annually in the fourth quarter of each fiscal year and whenever a plan is determined to qualify for a remeasurement during a fiscal year. The remaining components of our net periodic benefit cost are recorded on a quarterly basis. In connection with the changes in accounting policy for pension and other postretirement benefits and to properly match the actual operational expenses each business segment is incurring, we changed our allocation of net periodic benefit cost. We now allocate only the service cost and amortization of prior service cost components of our pension and postretirement plans to each business segment on a ratable basis. All other components of net periodic benefit cost (interest cost, estimated return on assets and net actuarial gains and losses) are recorded to Other Activities as these components are considered financing activities managed at the corporate level. Financial information for prior periods has been retrospectively adjusted. Forward-Looking Statements This release may contain “forward-looking statements,” which include information concerning the company's plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this release. These risks and uncertainties include, among other things: changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry business cycles, particularly in the automotive, electrical, electronics and construction industries; changes in the price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources; the ability to pass increases in raw material prices on to customers or otherwise improve margins through price increases; the ability to maintain plant utilization rates and to implement planned capacity additions and expansions; the ability to improve productivity by implementing technological improvements to existing plants; increased price competition and the introduction of competing products by other companies; market acceptance of our technology; the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the company; changes in the degree of intellectual property and other legal protection afforded to our products or technology, or the theft of such intellectual property; compliance and other costs and potential disruption or interruption of production or operations due to accidents, cyber security incidents, terrorism or political unrest or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, including the occurrence of acts of war or terrorist incidents or as a result of weather or natural disasters; potential liability for remedial actions and increased costs under existing or future environmental regulations, including those relating to climate change; potential liability resulting from pending or future litigation, or from changes in the laws, regulations or policies of governments or other governmental activities in the countries in which we operate; changes in currency exchange rates and interest rates; our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemicals industry; and various other factors discussed from time to time in the company's filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. Reconciliation of Non-U.S. GAAP Measures to U.S. GAAP This release reflects the following performance measures: adjusted EBIT, operating EBITDA, adjusted earnings per share and net debt as non-U.S. GAAP measures. These measurements are not recognized in accordance with U.S. GAAP and should not be viewed as an alternative to U.S. GAAP measures of performance. The most directly comparable financial measure presented in accordance with U.S. GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss); for adjusted earnings per share is earnings per common share-diluted; and for net debt is total debt. Use of Non-U.S. GAAP Financial Information • Adjusted EBIT is defined by the company as net earnings (loss) less interest income plus loss (earnings) from discontinued operations, interest expense and taxes, and further adjusted for other charges and other adjustments. We believe that adjusted EBIT is more reflective of our operations as it provides transparency to investors and enhances period-to-period comparability of our operations and financial performance. Our management believes adjusted EBIT is an important measure of our operating performance because it allows management, investors and analysts to evaluate and assess our core operating results from period to period after removing the impact of unusual, non-operational or restructuring-related activities that affect comparability. Our management recognizes that adjusted EBIT has inherent limitations because of the excluded items. Adjusted EBIT is one of the measures management uses for its planning and budgeting process to monitor and evaluate financial and operating results and for the company's incentive compensation plan. We may provide guidance on adjusted EBIT and are unable to reconcile forecasted adjusted EBIT to a U.S. GAAP financial measure because a forecast of other charges and other adjustments is not practical. Adjusted EBIT by business segment may also be referred to by management as segment income. Adjusted EBIT margin is defined by the company as Adjusted EBIT divided by net sales. • Operating EBITDA is defined by the company as net earnings (loss) less interest income plus loss (earnings) from discontinued operations, interest expense, taxes, and depreciation and amortization, and further adjusted for other charges and other adjustments. Operating EBITDA is equal to adjusted EBIT plus depreciation and amortization, and has the same uses and limitations as adjusted EBIT described above. • Adjusted earnings per share is a measure used by management to measure performance. It is defined by the company as earnings (loss) from continuing operations, adjusted for other charges and other adjustments, and divided by the number of basic common shares, convertible preferred shares and dilutive restricted stock units and stock options calculated using the treasury method. We may provide guidance on an adjusted earnings per share basis and are unable to reconcile forecasted adjusted earnings per share to a U.S. GAAP financial measure without unreasonable effort because a forecast of other charges and other adjustments is not practical. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding various financial and business trends relating to our financial condition and results of operations, and that when U.S. GAAP information is viewed in conjunction with non-U.S. GAAP information, investors are provided with a more meaningful understanding of our ongoing operating performance. Note: The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities, where applicable, and specifically excludes changes in uncertain tax positions, discrete items and other material items adjusted out of our U.S. GAAP 5 -------------------------------------------------------------------------------- earnings for adjusted earnings per share purposes, and changes in management's assessments regarding the ability to realize deferred tax assets. We analyze this rate quarterly and adjust if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the tax rate used for U.S. GAAP reporting in any given reporting period. It is not practical to reconcile our prospective adjusted tax rate to the actual U.S. GAAP tax rate in any given future period. • Net debt is defined by the company as total debt less cash and cash equivalents. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding changes to the company's capital structure. Our management and credit analysts use net debt to evaluate the company's capital structure and assess credit quality. Results Unaudited The results presented in this release, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year. -------------------------------------------------------------------------------- 6 -------------------------------------------------------------------------------- Consolidated Statements of Operations - Unaudited Three Months Ended March 31, 2013 2012 As Adjusted (In $ millions, except share and per share data) Net sales 1,605 1,633 Cost of sales (1,272 ) (1,359 ) Gross profit 333 274 Selling, general and administrative expenses (106 ) (126 ) Amortization of intangible assets (11 ) (13 ) Research and development expenses (26 ) (25 ) Other (charges) gains, net (4 ) — Foreign exchange gain (loss), net (1 ) 1 Gain (loss) on disposition of businesses and asset, net (1 ) — Operating profit (loss) 184 111 Equity in net earnings (loss) of affiliates 54 51 Interest expense (43 ) (45 ) Refinancing expense — — Interest income — 1 Dividend income - cost investments 24 — Other income (expense), net (1 ) 2 Earnings (loss) from continuing operations before tax 218 120 Income tax (provision) benefit (77 ) 73 Earnings (loss) from continuing operations 141 193 Earnings (loss) from operation of discontinued operations 2 — Gain (loss) on disposition of discontinued operations — — Income tax (provision) benefit, discontinued operations (1 ) — Earnings (loss) from discontinued operations 1 — Net earnings (loss) 142 193 Net earnings (loss) attributable to noncontrolling interests — — Net earnings (loss) attributable to Celanese Corporation 142 193 Cumulative preferred stock dividends — — Net earnings (loss) available to common shareholders 142 193 Amounts attributable to Celanese Corporation Earnings (loss) per common share - basic Continuing operations 0.88 1.23 Discontinued operations 0.01 — Net earnings (loss) - basic 0.89 1.23 Earnings (loss) per common share - diluted Continuing operations 0.88 1.21 Discontinued operations 0.01 — Net earnings (loss) - diluted 0.89 1.21 Weighted average shares (in millions) Basic 159.7 156.5 Diluted 160.2 159.1 7 -------------------------------------------------------------------------------- Consolidated Balance Sheets - Unaudited As of As of March 31, December 31, 2013 2012 As Adjusted (In $ millions) ASSETS Current assets Cash & cash equivalents 978 959 Trade receivables - third party and affiliates, net 916 827 Non-trade receivables, net 197 209 Inventories 758 711 Deferred income taxes 50 49 Marketable securities, at fair value 49 53 Other assets 38 31 Total current assets 2,986 2,839 Investments in affiliates 796 800 Property, plant and equipment, net 3,286 3,350 Deferred income taxes 603 606 Other assets 480 463 Goodwill 762 777 Intangible assets, net 155 165 Total assets 9,068 9,000 LIABILITIES AND EQUITY Current liabilities Short-term borrowings and current installments of long-term debt - third party and affiliates 112 168 Trade payables - third party and affiliates 659 649 Other liabilities 459 475 Deferred income taxes 25 25 Income taxes payable 96 38 Total current liabilities 1,351 1,355 Long-term debt 2,959 2,930 Deferred income taxes 44 50 Uncertain tax positions 180 181 Benefit obligations 1,576 1,602 Other liabilities 1,123 1,152 Commitments and contingencies Stockholders' equity Preferred stock — — Common stock — — Treasury stock, at cost (905 ) (905 ) Additional paid-in capital 736 731 Retained earnings 2,123 1,993 Accumulated other comprehensive income (loss), net (119 ) (89 ) Total Celanese Corporation stockholders' equity 1,835 1,730 Noncontrolling interests — — Total equity 1,835 1,730 Total liabilities and equity 9,068 9,000 8 -------------------------------------------------------------------------------- Table 1 Reconciliation of Consolidated Net Earnings (Loss) to Adjusted EBIT and Operating EBITDA - Non-U.S. GAAP Measures - Unaudited Three Months Ended March 31, 2013 2012 As Adjusted (In $ millions) Net earnings (loss) 142 193 (Earnings) loss from discontinued operations (1 ) — Interest income — (1 ) Interest expense 43 45 Refinancing expense — — Income tax provision (benefit) 77 (73 ) Other charges (gains), net (1) 4 — Other adjustments (1) 4 32 Adjusted EBIT 269 196 Depreciation and amortization expense (2) 76 72 Operating EBITDA 345 268 Three Months Ended March 31, 2013 2012 (In $ millions) Advanced Engineered Materials — — Consumer Specialties — — Industrial Specialties — 2 Acetyl Intermediates — — Other Activities (3) — — Accelerated depreciation and amortization expense — 2 Depreciation and amortization expense (2) 76 72 Total depreciation and amortization expense 76 74 ______________________________ (1) See Table 8 for details. (2) Excludes accelerated depreciation and amortization expense as detailed in the table above and included in Other adjustments above. (3) Other Activities includes corporate selling, general and administrative expenses and the results from captive insurance companies. 9 -------------------------------------------------------------------------------- Table 2 Segment Data and Reconciliation of Operating Profit (Loss) to Adjusted EBIT and Operating EBITDA - Non-U.S. GAAP Measures - Unaudited Three Months Ended March 31, 2013 2012 As Adjusted (In $ millions, except percentages) Operating Profit (Loss) / Operating Margin (1) Advanced Engineered Materials 36 10.9 % 24 7.6 % Consumer Specialties 78 26.4 % 40 15.2 % Industrial Specialties 15 5.2 % 20 6.5 % Acetyl Intermediates 75 9.3 % 62 7.3 % Other Activities (2) (20 ) (35 ) Total 184 11.5 % 111 6.8 % Equity Earnings, Cost - Dividend Income and Other Income (Expense) Advanced Engineered Materials 40 43 Consumer Specialties 26 1 Industrial Specialties — — Acetyl Intermediates 3 1 Other Activities (2) 8 8 Total 77 53 Other Charges and Other Adjustments (3) Advanced Engineered Materials 2 3 Consumer Specialties 4 17 Industrial Specialties 1 2 Acetyl Intermediates 1 2 Other Activities (2) — 8 Total 8 32 Adjusted EBIT / Adjusted EBIT Margin (1) Advanced Engineered Materials 78 23.7 % 70 22.1 % Consumer Specialties 108 36.6 % 58 22.0 % Industrial Specialties 16 5.6 % 22 7.1 % Acetyl Intermediates 79 9.8 % 65 7.6 % Other Activities (2) (12 ) (19 ) Total 269 16.8 % 196 12.0 % Depreciation and Amortization Expense (4) Advanced Engineered Materials 29 27 Consumer Specialties 10 9 Industrial Specialties 12 13 Acetyl Intermediates 21 20 Other Activities (2) 4 3 Total 76 72 Operating EBITDA Advanced Engineered Materials 107 97 Consumer Specialties 118 67 Industrial Specialties 28 35 Acetyl Intermediates 100 85 Other Activities (2) (8 ) (16 ) Total 345 268 ______________________________ (1) Defined as operating profit (loss) and adjusted EBIT, respectively, divided by net sales. See Table 4 for net sales. (2) Other Activities includes corporate selling, general and administrative expenses and the results from captive insurance companies. (3) See Table 8 for details. (4) Excludes accelerated depreciation and amortization expense. See Table 1 for details. 10 -------------------------------------------------------------------------------- Table 3 Adjusted Earnings (Loss) Per Share - Reconciliation of a Non-U.S. GAAP Measure - Unaudited Three Months Ended March 31, 2013 2012 As Adjusted per per share share (In $ millions, except per share data) Earnings (loss) from continuing operations 141 0.88 193 1.21 Deduct: Income tax (provision) benefit (77 ) 73 Earnings (loss) from continuing operations before tax 218 120 Other charges and other adjustments (1) 8 32 Refinancing expense — — Adjusted earnings (loss) from continuing operations before tax 226 152 Income tax (provision) benefit on adjusted earnings (2) (43 ) (26 ) Noncontrolling interests — — Adjusted earnings (loss) from continuing operations 183 1.14 126 0.79 Diluted shares (in millions) (3) Weighted average shares outstanding 159.7 156.5 Dilutive stock options 0.2 1.9 Dilutive restricted stock units 0.3 0.7 Total diluted shares 160.2 159.1 ______________________________ (1) See Table 8 for details. (2) The adjusted effective tax rate is 19% and 17% for the three months ended March 31, 2013 and 2012, respectively. (3) Potentially dilutive shares are included in the adjusted earnings per share calculation when adjusted earnings are positive. Table 4 Factors Affecting Segment Net Sales - Unaudited Three Months Ended March 31, 2013 2012 (In $ millions) Net Sales Advanced Engineered Materials 329 317 Consumer Specialties 295 264 Industrial Specialties 288 309 Acetyl Intermediates 808 852 Other Activities (1) — — Intersegment eliminations (115 ) (109 ) Total 1,605 1,633 ______________________________ (1) Other Activities includes corporate selling, general and administrative expenses and the results from captive insurance companies. Three Months Ended March 31, 2013 Compared to Three Months Ended March 31, 2012 Volume Price Currency Other Total (In percentages) Advanced Engineered Materials — 4 — — 4 Consumer Specialties 5 7 — — 12 Industrial Specialties (3 ) (4 ) — — (7 ) Acetyl Intermediates (4 ) (1 ) — — (5 ) Total Company (2 ) — — — (2 ) 11 -------------------------------------------------------------------------------- Table 5 Cash Flow Information - Unaudited Three Months Ended March 31, 2013 2012 As Adjusted (In $ millions) Net cash provided by operating activities 147 215 Net cash (used in) investing activities (1) (87 ) (155 ) Net cash (used in) financing activities (35 ) (21 ) Exchange rate effects on cash and cash equivalents (6 ) 6 Cash and cash equivalents at beginning of period 959 682 Cash and cash equivalents at end of period 978 727 ______________________________ (1) 2013 and 2012 include $3 million and $21 million, respectively, of capital expenditures related to the relocation of our Kelsterbach, Germany POM operations. Table 6 Cash Dividends Received - Unaudited Three Months Ended March 31, 2013 2012 (In $ millions) Dividends from equity investments 47 111 Dividends from cost investments 24 — Total 71 111 Table 7 Net Debt - Reconciliation of a Non-U.S. GAAP Measure - Unaudited As of As of March 31, December 31, 2013 2012 (In $ millions) Short-term borrowings and current installments of long-term debt - third party and affiliates 112 168 Long-term debt 2,959 2,930 Total debt 3,071 3,098 Less: Cash and cash equivalents 978 959 Net debt 2,093 2,139 12 -------------------------------------------------------------------------------- Table 8 Other Charges and Other Adjustments - Reconciliation of a Non-U.S. GAAP Measure - Unaudited Other Charges (Gains), net: Three Months Ended March 31, 2013 2012 (In $ millions) Employee termination benefits 2 — Kelsterbach plant relocation 2 — Total 4 — Other Adjustments: (1) Three Months Ended March 31, Income Statement 2013 2012 Classification (In $ millions) Business optimization — 5 SG&A Kelsterbach plant relocation — 3 Cost of sales Cost of sales / Plant closures 1 4 SG&A Acetate production interruption costs — 10 Cost of sales Other 3 10 Various Total 4 32 Total other charges and other adjustments 8 32 ______________________________ (1) These items are included in net earnings but not included in Other charges (gains), net. 13 EX-99.2 3 a1q2013earningsslides18a.htm EX 99.2 - SLIDES [[Image Removed]] 1 Mark Rohr, Chairman and Chief Executive Officer Steven Sterin, Senior Vice President and Chief Financial Officer Celanese Q1 2013 Earnings Thursday, April 18, 2013 Conference Call / Webcast Friday, April 19, 2013 10:00 a.m. EDT EX 99.2 -------------------------------------------------------------------------------- [[Image Removed]] 2 Change in accounting policy regarding pension and other postretirement benefits Effective January 1, 2013, we elected to change our policy for recognizing actuarial gains and losses and the change in fair value of plan assets for our defined benefit pension plans and other postretirement benefit plans. We now immediately recognize the change in fair value of plan assets and net actuarial gains and losses annually in the fourth quarter of each fiscal year and whenever a plan is determined to qualify for a re-measurement during a fiscal year. The remaining components of our net periodic benefit cost are recorded on a quarterly basis. In connection with the changes in accounting policy for pension and other postretirement benefits and to properly match the actual operational expenses each business segment is incurring, we changed our allocation of net periodic benefit cost. We now allocate only the service cost and amortization of prior service cost components of our pension and postretirement plans to each business segment on a ratable basis. All other components of net periodic benefit cost (interest cost, estimated return on assets and net actuarial gains and losses) are recorded to Other Activities as these components are considered financing activities managed at the corporate level. Financial information for prior periods has been retrospectively adjusted. Forward-Looking Statements This presentation, and public statements made in connection with this presentation, may contain “forward-looking statements,” which include information concerning the company's plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this release. These risks and uncertainties include, among other things: changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry business cycles, particularly in the automotive, electrical, electronics and construction industries; changes in the price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources; the ability to pass increases in raw material prices on to customers or otherwise improve margins through price increases; the ability to maintain plant utilization rates and to implement planned capacity additions and expansions; the ability to improve productivity by implementing technological improvements to existing plants; increased price competition and the introduction of competing products by other companies; market acceptance of our technology; the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the company; changes in the degree of intellectual property and other legal protection afforded to our products or technology, or the theft of such intellectual property; compliance and other costs and potential disruption or interruption of production or operations due to accidents, cyber security incidents, terrorism or political unrest or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, including the occurrence of acts of war or terrorist incidents or as a result of weather or natural disasters; potential liability for remedial actions and increased costs under existing or future environmental regulations, including those relating to climate change; potential liability resulting from pending or future litigation, or from changes in the laws, regulations or policies of governments or other governmental activities in the countries in which we operate; changes in currency exchange rates and interest rates; our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemicals industry; and various other factors discussed from time to time in the company's filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. Results Unaudited The results presented in this release, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year. -------------------------------------------------------------------------------- [[Image Removed]] 3 Non-US GAAP Financial Information Reconciliation of Non-U.S. GAAP Measures to U.S. GAAP This presentation reflects the following performance measures: adjusted EBIT, operating EBITDA, adjusted earnings per share, net debt and adjusted free cash flow as non-U.S. GAAP measures. These measurements are not recognized in accordance with U.S. GAAP and should not be viewed as an alternative to U.S. GAAP measures of performance. The most directly comparable financial measure presented in accordance with U.S. GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss); for adjusted earnings per share is earnings per common share-diluted; for net debt is total debt; and for adjusted free cash flow is cash flow from operations. Use of Non-U.S. GAAP Financial Information ? Adjusted EBIT is defined by the company as net earnings (loss) less interest income plus loss (earnings) from discontinued operations, interest expense and taxes, and further adjusted for other charges and other adjustments. We believe that adjusted EBIT is more reflective of our operations as it provides transparency to investors and enhances period-to-period comparability of our operations and financial performance. Our management believes adjusted EBIT is an important measure of our operating performance because it allows management, investors and analysts to evaluate and assess our core operating results from period to period after removing the impact of unusual, non-operational or restructuring-related activities that affect comparability. Our management recognizes that adjusted EBIT has inherent limitations because of the excluded items. Adjusted EBIT is one of the measures management uses for its planning and budgeting process to monitor and evaluate financial and operating results and for the company's incentive compensation plan. We may provide guidance on adjusted EBIT and are unable to reconcile forecasted adjusted EBIT to a U.S. GAAP financial measure because a forecast of other charges and other adjustments is not practical. Adjusted EBIT by business segment may also be referred to by management as segment income. Adjusted EBIT margin is defined by the company as adjusted EBIT divided by net sales. ? Operating EBITDA is defined by the company as net earnings (loss) less interest income plus loss (earnings) from discontinued operations, interest expense, taxes, and depreciation and amortization, and further adjusted for other charges and other adjustments. Operating EBITDA is equal to adjusted EBIT plus depreciation and amortization, and has the same uses and limitations as adjusted EBIT described above. ? Adjusted earnings per share is a measure used by management to measure performance. It is defined by the company as earnings (loss) from continuing operations, adjusted for other charges and other adjustments, and divided by the number of basic common shares, convertible preferred shares and dilutive restricted stock units and stock options calculated using the treasury method. We may provide guidance on an adjusted earnings per share basis and are unable to reconcile forecasted adjusted earnings per share to a U.S. GAAP financial measure without unreasonable effort because a forecast of other charges and other adjustments is not practical. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding various financial and business trends relating to our financial condition and results of operations, and that when U.S. GAAP information is viewed in conjunction with non-U.S. GAAP information, investors are provided with a more meaningful understanding of our ongoing operating performance. Note: The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities, where applicable, and specifically excludes changes in uncertain tax positions, discrete items and other material items adjusted out of our U.S. GAAP earnings for adjusted earnings per share purposes, and changes in management's assessments regarding the ability to real ize deferred tax assets. We analyze this rate quarterly and adjust if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the tax rate used for U.S. GAAP reporting in any given reporting period. It is not practical to reconcile our prospective adjusted tax rate to the actual U.S. GAAP tax rate in any given future period. ? Net debt is defined by the company as total debt less cash and cash equivalents. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding changes to the company's capital structure. Our management and credit analysts use net debt to evaluate the company's capital structure and assess credit quality. ? Adjusted free cash flow is defined by the company as cash flow from operations less other productive asset purchases, operating cash from discontinued operations and certain other charges and other adjustments. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding changes to the company’s cash flow. Our management and credit analysts use adjusted free cash flow to eva luate the company’s liquidity and assess credit quality. Although we use adjusted free cash flow as a financial measure to assess the performance of our business, the use of adjusted free cash flow has important limitations, including that adjusted free cash flow does not reflect the cash requirements necessary to service our indebtedness, lease obligations, unconditional purchase obligations or pension and postretirement funding obligations. -------------------------------------------------------------------------------- [[Image Removed]] 4 Mark Rohr Chairman and Chief Executive Officer -------------------------------------------------------------------------------- [[Image Removed]] 5 Improved transparency and consistency Note: *For additional details and adjusted historical data pertaining to mark-to-market accounting, please refer to the company’s current report on Form 8-K furnished to the SEC on April 2, 2013 available at www.celanese.com under the Investor Relations section. Plans refer to pension and other postretirement benefit (“OPEB”) plans ? Adopted mark-to-market ("MTM") pension accounting*: Recognize gains and losses related to the plans’* investments and interest rate changes in the year they occur, rather than amortizing over future periods ? Expect quarterly dividends from our China acetate ventures rather than annual dividends -------------------------------------------------------------------------------- [[Image Removed]] 6 Long-term Strategic Activities ? Signed a Memorandum of Understanding (MOU) with Pertamina ? Intend to establish a JV with CE majority share ? CE would license its leading TCXฎ Technology to the venture ? Expect to complete this phase of MOU by end of 2013 Indonesia fuel ethanol ? Unit mechanically complete ? Actively working with customers to commercialize ? Commercial sales expected in third and fourth quarters of this year ? Expect to divert merchant acid volume resulting in elevated acid capacity utilization Nanjing industrial ethanol ? Completed design ? Began ordering long lead-time equipment ? Timeline consistent with being operational by mid-2015 ? Confident in ability to secure environmental credits ? Finalizing structure and agreement with potential partner Clear Lake methanol -------------------------------------------------------------------------------- [[Image Removed]] 7 ? 44% YoY* and 54% QoQ* growth of adjusted EPS including Acetate dividend of $24 million ? Adjusted EBIT margins of 16.8% ? Operating cash flow of $147 million and adjusted free cash flow of $64 million Celanese Corporation Q1 2013 Highlights Q1 2012** $0.79 Q4 2012** $0.74 Q1 2013 $1.14 Adjusted EPS $1,633 $1,501 $1,605 12.0% 12.5% 16.8% 0% 10% 20% 30% $0 $600 $1,200 $1,800 Q1 2012 Q4 2012 Q1 2013 Q1 Performance Net Sales (in millions) Adjusted EBIT margin Factors Affecting Net Sales Changes -2% 0% 0% 0% -2% 7% -1% 1% 1% 6% Volume Price Currency Other Total QoQ* YoY* Note: *QoQ represents Q1 2013 as compared to Q4 2012; YoY represents Q1 2013 compared to Q1 2012. **Adjusted to include MTM pension impact. For additional details and adjusted historical data, please refer to the company’s current report on Form 8-K furnished to the SEC on April 2, 2013 available at www.celanese.com under the Investor Relations section. -------------------------------------------------------------------------------- [[Image Removed]] 8 QoQ adjusted EBIT highlights ? Increased auto applications more than offset ongoing weakness in European auto builds ? Favorable product mix, higher medical applications ? Raw materials slightly favorable ? Lower affiliate earnings due to lower MTBE pricing in Ibn Sina Q1 Performance Factors Affecting Net Sales Changes Advanced Engineered Materials 4% 0% 0% 4% 0% 10% 0% 1% 3% 6% Volume Price Currency Other Total YoY adjusted EBIT highlights ? Increased auto applications more than offset ongoing weakness in European auto builds ? Improved product mix, higher medical applications QoQ YoY $317 $299 $329 22.1% 20.7% 23.7% 0% 10% 20% 30% 40% $0 $100 $200 $300 $400 Q1 2012 Q4 2012 Q1 2013 Net Sales (in millions) Adjusted EBIT margin -------------------------------------------------------------------------------- [[Image Removed]] 9 QoQ adjusted EBIT highlights ? $24 million in cash dividends from China acetate ventures ? Operational reliability and higher pricing more than offset higher raw material costs ? Ceased production at Spondon lowering energy and operating costs Consumer Specialties Q1 Performance Factors Affecting Net Sales Changes 12% 0% 0% 7% 5% 5% 0% 0% 5% 0% Volume Price Currency Other Total YoY adjusted EBIT highlights ? $24 million in cash dividends from China acetate ventures ? Continued strong demand in Acetate business ? Ceased production at Spondon lowering energy and operating costs ? Acetate production interruption in first quarter of 2012 did not occur in 2013 QoQ YoY $264 $281 $295 22.0% 27.8% 36.6% 0% 15% 30% 45% $0 $100 $200 $300 Q1 2012 Q4 2012 Q1 2013 Net Sales (in millions) Adjusted EBIT margin -------------------------------------------------------------------------------- [[Image Removed]] 10 QoQ adjusted EBIT highlights ? Seasonal trends in Emulsions in Europe and North America ? Raw materials stable ? Continued poor photovoltaic demand for some EVA products Industrial Specialties Q1 Performance Factors Affecting Net Sales Changes -7% 0% 0% -4% -3% 15% 0% 1% 0% 14% Volume Price Currency Other Total YoY adjusted EBIT highlights ? Lower Emulsions demand in North America and Europe partially offset by stronger demand in Asia for VAE applications ? Lower demand for photovoltaic applications in EVA and lower raw materials, primarily ethylene, in Emulsions QoQ YoY $309 $251 $288 7.1% 2.4% 5.6% -3% 2% 7% 12% $0 $100 $200 $300 Q1 2012 Q4 2012 Q1 2013 Net Sales (in millions) Adjusted EBIT margin -------------------------------------------------------------------------------- [[Image Removed]] 11 QoQ adjusted EBIT highlights ? Improved demand for acetic acid and downstream derivatives in North America and Asia outside of China ? Demand in China lower due to the timing of Chinese New Year Acetyl Intermediates Q1 Performance Factors Affecting Net Sales Changes -5% 0% 0% -1% -4% 5% 0% 1% -1% 5% Volume Price Currency Other Total YoY adjusted EBIT highlights ? Global demand for acetyl products and downstream derivatives remained weak ? Expanded adjusted EBIT margins on cost efficiencies and lower raw material costs QoQ YoY $852 $773 $808 7.6% 8.9% 9.8% 0% 4% 8% 12% $0 $300 $600 $900 Q1 2012 Q4 2012 Q1 2013 Net Sales (in millions) Adjusted EBIT margin -------------------------------------------------------------------------------- [[Image Removed]] 12 Innovation success Electronics Automotive ? Initial application around the compact camera module on existing platform ? Expanded to a handful of applications on the new platform rolling out this summer ? Opportunity beyond smartphones in other electronic devices ? Polymer chemistry combined with material engineering capabilities ? Significant increase of CE applications in the redesign of GM's light duty truck platform These innovation initiatives allow CE to deliver growth -------------------------------------------------------------------------------- [[Image Removed]] 13 April: Outlook for 2013 Segment Income outlook Celanese • Continue to drive productivity programs Advanced Engineered Materials • Base business growth due to breath of portfolio, despite weakness in European auto build • Offset by timing of turnarounds at affiliates Consumer Specialties • Ceased production at Spondon • Expansion at China acetate venture in Nantong Industrial Specialties • Increased adoption of VAE in paints in China • Continued weak demand in EVA photovoltaic application Acetyl Intermediates • Current demand conditions to continue as global GDP remains soft • Nanjing industrial ethanol on-track and commercial sales expected in third and fourth quarter Higher vs. 2012 Flat vs. 2012 Working to achieve 12-14% adjusted earnings growth in 2013 -------------------------------------------------------------------------------- [[Image Removed]] 14 Steven Sterin Senior Vice President and Chief Financial Officer -------------------------------------------------------------------------------- [[Image Removed]] 15 Track record of strong cash flow generation $215 $147 $112 $64 Q1 2012 Q1 2013 Cash Flow from Operations Adjusted Free Cash Flow Adjusted Free Cash Flow (off Operating EBITDA base) in millions Cash Taxes $175 - $225 Capital Expenditures $375 - $400 Reserve Spending $0 - $50 Net Interest $180 - $190 Pension/OPEB $75 - $125 Change in TWC $50 - $100 (in millions) 2013 Adjusted Free Cash Outflows ? Q1 2012: ? Lower working capital requirements due to destocking in Europe and Asia ? Operating cash flow included a nonrecurring special cash dividend from one of our Asian affiliates ? Q1 2013 ? Received a $24 million quarterly dividend from our China acetate ventures -------------------------------------------------------------------------------- [[Image Removed]] 16 Improved credit profile and continue to return cash to shareholders ? Reduced net debt to just below $2.1 billion as of March 31, 2013, second lowest quarterly level in eight years ? Improved net debt leverage and interest coverage ratios 2009 2010 2011 2012 ? Steadily increased our dividend at >20% CAGR ? ~$400 million remaining share repurchase authorization Improved Credit Profile Dividend Growth 3.9x 5.4x 6.2x 6.8x 7.3x 2.8x 2.3x 1.7x 1.7x 1.6x 0x 2x 4x 6x 8x Operating EBITDA/ Interest Expense Net Debt/ Operating EBITDA -------------------------------------------------------------------------------- [[Image Removed]] 17 Tax rate discussion Q1 2012 -61% Q1 2013 35% Effective US GAAP tax rate ? Q1 2012 tax benefit driven by recognition of $142 million of foreign tax credit ? Q1 2013 higher proportion of earnings in United States with high statutory rates ? Expect adjusted tax rate of 19% for 2013 Q1 2012 17% Q1 2013 19% Adjusted EPS tax rate -------------------------------------------------------------------------------- [[Image Removed]] 18 Appendix -------------------------------------------------------------------------------- [[Image Removed]] 19 Reconciliation of Consolidated Net Earnings (Loss) to Adjusted EBIT and Operating EBITDA - Non U.S. GAAP Measures - Unaudited March 31, December 31, March 31, LTM (1) 2013 2012 2012 2013 2012 2011 2010 2009 Net earnings (loss) 142 (169) 193 321 372 427 312 403 (Earnings) loss from discontinued operations (1) 2 — 3 4 (1) 49 (4) Interest income — (1) (1) (1) (2) (3) (7) (8) Interest expense 43 51 45 183 185 221 204 207 Refinancing expense — 3 — 3 3 3 16 — Income tax provision (benefit) 77 (96) (73) 95 (55) 41 72 (294) Other charges (gains), net (2) 4 13 — 18 14 48 46 136 Other adjustments (2) 4 385 32 413 441 357 151 85 Adjusted EBIT 269 188 196 1,035 962 1,093 843 525 Depreciation and amortization expense (3) 76 79 72 304 300 287 258 290 Operating EBITDA 345 267 268 1,339 1,262 1,380 1,101 815 Operating EBITDA / Interest Expense 7.3 6.8 6.2 5.4 3.9 March 31, December 31, March 31, LTM (1) 2013 2012 2012 2013 2012 2011 2010 2009 Advanced Engineered Materials — — — — — 3 4 1 Consumer Specialties — 2 — 6 6 8 5 — Industrial Specialties — — 2 — 2 — — 5 Acetyl Intermediates — — — — — — 20 12 Other Activities (4) — — — — — — — — Accelerated depreciation and amortization expense — 2 2 6 8 11 29 18 Depreciation and amortization expense (3) 76 79 72 304 300 287 258 290 Total depreciation and amortization expense 76 81 74 310 308 298 287 308 ____________________ (1) Last twelve months as of March 31, 2013. (2) See Other charges and Other adjustments reconciliation for details. (3) Excludes accelerated depreciation and amortization expense as detailed in the table above and included in Other adjustments above. (4) Other Activities includes corporate selling, general and administrative expenses and the results from captive insurance companies. Three Months Ended Three Months Ended (In $ millions) Year Ended December 31, As Adjusted (In $ millions) Year Ended December 31, -------------------------------------------------------------------------------- [[Image Removed]] 20 Segment Data and Reconciliation of Operating Profit (Loss) to Adjusted EBIT and Operating EBITDA - Non-U.S. GAAP Measures - Unaudited N et S al es A dv an ce d En gi ne er ed M at er ia ls 32 9 29 9 31 7 C on su m er S pe ci al tie s 29 5 28 1 26 4 I nd us tr ia l S pe ci al tie s 28 8 25 1 30 9 A ce ty l I nt er m ed ia te s 80 8 77 3 85 2 O th er A ct iv iti es ( 1) — — — I nt er se gm en t e lim in at io ns (1 15 ) (1 03 ) (1 09 ) T ot al 1, 60 5 1, 50 1 1, 63 3 O pe ra ti ng P ro fi t ( L os s) / O pe ra ti ng M ar gi n (2 ) A dv an ce d En gi ne er ed M at er ia ls 36 10 .9 % 4 1. 3% 24 7. 6% C on su m er S pe ci al tie s 78 26 .4 % 62 22 .1 % 40 15 .2 % I nd us tr ia l S pe ci al tie s 15 5. 2% 6 2. 4% 20 6. 5% A ce ty l I nt er m ed ia te s 75 9. 3% 66 8. 5% 62 7. 3% O th er A ct iv iti es ( 1) (2 0) (4 28 ) (3 5) T ot al 18 4 11 .5 % (2 90 ) -1 9. 3% 11 1 6. 8% Eq ui ty E ar ni ng s, C os t - D iv id en d In co m e an d O th er In co m e (E xp en se ) A dv an ce d En gi ne er ed M at er ia ls 40 47 43 C on su m er S pe ci al tie s 26 5 1 I nd us tr ia l S pe ci al tie s — — — A ce ty l I nt er m ed ia te s 3 8 1 O th er A ct iv iti es ( 1) 8 20 8 T ot al 77 80 53 O th er C ha rg es a nd O th er A dj us tm en ts (3 ) A dv an ce d En gi ne er ed M at er ia ls 2 11 3 C on su m er S pe ci al tie s 4 11 17 I nd us tr ia l S pe ci al tie s 1 — 2 A ce ty l I nt er m ed ia te s 1 (5 ) 2 O th er A ct iv iti es ( 1) — 38 1 8 T ot al 8 39 8 32 A dj us te d EB IT / A dj us te d EB IT M ar gi n (2 ) A dv an ce d En gi ne er ed M at er ia ls 78 23 .7 % 62 20 .7 % 70 22 .1 % C on su m er S pe ci al tie s 10 8 36 .6 % 78 27 .8 % 58 22 .0 % I nd us tr ia l S pe ci al tie s 16 5. 6% 6 2. 4% 22 7. 1% A ce ty l I nt er m ed ia te s 79 9. 8% 69 8. 9% 65 7. 6% O th er A ct iv iti es ( 1) (1 2) (2 7) (1 9) T ot al 26 9 16 .8 % 18 8 12 .5 % 19 6 12 .0 % D ep re ci at io n an d A m or ti za ti on E xp en se (4 ) A dv an ce d En gi ne er ed M at er ia ls 29 29 27 C on su m er S pe ci al tie s 10 10 9 I nd us tr ia l S pe ci al tie s 12 14 13 A ce ty l I nt er m ed ia te s 21 21 20 O th er A ct iv iti es ( 1) 4 5 3 T ot al 76 79 72 O pe ra ti ng E B IT D A A dv an ce d En gi ne er ed M at er ia ls 10 7 91 97 C on su m er S pe ci al tie s 11 8 88 67 I nd us tr ia l S pe ci al tie s 28 20 35 A ce ty l I nt er m ed ia te s 10 0 90 85 O th er A ct iv iti es ( 1) (8 ) (2 2) (1 6) T ot al 34 5 26 7 26 8 __ __ __ __ __ __ __ __ __ __ (1 ) O th er A ct iv iti es in cl ud es c or por at e se lli ng , g en er al a nd ad m in is tr at iv e ex pe ns es a nd th e r es ul ts fro m c ap tiv e in sur an ce c om pa ni es . (2 ) D ef in ed as o pe ra tin g prof it ( lo ss ) a nd ad ju st ed EBI T , r es pe ct iv el y, d iv id ed b y n et s al es . (3 ) S ee O th er ch ar ge s and O th er ad ju st m en ts re con ili at ion for d et ai ls . (4 ) E xc lud es a cc el er at ed d ep re ci at ion and am or tiz at ion ex pe ns e in cl ud ed in O th er ch ar ge s and O th er ad ju st m en ts a bov e. A s A dj us te d (I n $ m il li on s) T hr ee M on th s En de d M ar ch 3 1, D ec em be r 31 , M ar ch 3 1, 20 13 20 12 20 12 -------------------------------------------------------------------------------- [[Image Removed]] 21 Adjusted Earnings (Loss) Per Share - Reconciliation of a Non- U.S. GAAP Measure - Unaudited per share per share per share per share Earnings (loss) from continuing operations 141 0.88 (167) (1.05) 193 1.21 376 2.35 Deduct: Income tax (provision) benefit (77) 96 73 55 Earnings (loss) from continuing operations before tax 218 (263) 120 321 Other charges and other adjustments (1) 8 398 32 455 Refinancing - related expenses — 8 — 8 Adjusted earnings (loss) from continuing operations before tax 226 143 152 784 Income tax (provision) benefit on adjusted earnings (2) (43) (24) (26) (133) Noncontrolling interests — — — — Adjusted earnings (loss) from continuing operations 183 1.14 119 0.74 126 0.79 651 4.07 Weighted average shares outstanding 159.7 159.5 156.5 158.3 Dilutive stock options 0.2 0.2 1.9 0.9 Dilutive restricted stock units 0.3 0.5 0.7 0.6 Total diluted shares 160.2 160.2 159.1 159.8 ____________________ December 31, 2012 Year Ended (In $ millions, except per share data) Three Months Ended March 31, December 31, March 31, 2013 2012 2012 Diluted shares (in millions) (3) As Adjusted (3) Potentially dilutive shares are included in the adjusted earnings per share calculation when adjusted earnings are positive. (1) See Other charges and Other adjustments reconciliation for details. (2) The adjuste effective tax rate is 19% for t three m ths ended March 31, 2013 and 17% for the three months ended March 31, 2012 and December 31, 2012 and for the year ended December 31, 2012. -------------------------------------------------------------------------------- [[Image Removed]] 22 Other Charges and Other Adjustments - Reconciliation of a Non-U.S. GAAP Measure - Unaudited Other Charges (Gains), net: March 31, December 31, March 31, LTM (1) 2013 2012 2012 2013 2012 2011 2010 2009 Employee termination benefits 2 4 — 8 6 22 32 105 Kelsterbach plant relocation 2 2 — 9 7 47 26 16 Plumbing actions — (1) — (5) (5) (6) (59) (10) Insurance recoveries — — — — — — (18) (6) Asset impairments — 8 — 8 8 1 74 14 Plant/office closures — — — — — — 4 17 Commercial disputes — — — (2) (2) (15) (13) — Other — — — — — (1) — — Total 4 13 — 18 14 48 46 136 Other Adjustments: (2) March 31, December 31, March 31, LTM (1) 2013 2012 2012 2013 2012 2011 2010 2009 Income Statement Classification As Adjusted Business optimization — 1 5 4 9 8 16 7 Cost of Sales / SG&A Kelsterbach plant relocation — 10 3 11 14 8 (13) — Cost of sales Plant closures 1 5 4 18 21 18 17 25 Cost of sales / SG&A Contract termination — — — — — — 22 — Cost of sales (Gain) on sale of PVOH business — — — — — — — (34) (Gain) loss on disposition (Gain) loss on disposition of assets — — — 1 1 (1) (10) — (Gain) loss on disposition Write-off of other productive assets — — — — — (1) 18 — Cost of sales Commercial disputes — — — — — 8 — — Cost of sales / SG&A Acetate production interruption costs — — 10 — 10 — — — Cost of sales InfraServ Hoechst debt restructuring — (22) — (22) (22) — — — Equity in net (earnings) loss of affiliates Actuarial loss on pension and postretirement plans — 389 — 389 389 306 84 104 Cost of sales / SG&A / R&D Othe 3 2 10 12 19 11 17 (17) Various Total 4 385 32 413 441 357 151 85 Total other charges and other adjustments 8 398 32 431 455 405 197 221 ____________________ (1) Last twelve months as of March 31, 2013. (2) These items are included in net earnings but not included in Other charges (gains), net. Year Ended December 31, As Adjusted (In $ millions) Three Months Ended Three Months Ended Year Ended December 31, (In $ millions) -------------------------------------------------------------------------------- [[Image Removed]] 23 Adjusted Free Cash Flow - Reconciliation of a Non-U.S. GAAP Measure - Unaudited 2013 2012 Net cash provided by operating activities 147 215 Adjustments to operating cash for discontinued operations (1) — Net cash provided by operating activities from continuing operations 146 215 Capital expenditures (74) (106) Cash flow adjustments (1) (8) 3 Adjusted free cash flow 64 112 ____________________ (1) Amounts primarily associated with Kelsterbach plant related cash expenses, and purchases of other productive assets that are classified as 'investing activities' for U.S. GAAP purposes. Three Months Ended (In $ millions) March 31, -------------------------------------------------------------------------------- [[Image Removed]] 24 Net Debt - Reconciliation of a Non-U.S. GAAP Measure - Unaudited LTM (1) March 31, 2013 2012 2011 2010 2009 Short-term borrowings and current installments of long-term debt - third party and affiliates 112 168 144 228 242 Long-term debt 2,959 2,930 2,873 2,990 3,259 Total debt 3,071 3,098 3,017 3,218 3,501 Less: cash and cash equivalents 978 959 682 740 1,254 Net debt 2,093 2,139 2,335 2,478 2,247 Operating EBITDA 1,339 1,262 1,380 1,101 815 Net debt / Operating EBITDA 1.6 1.7 1.7 2.3 2.8 ____________________ (1) Last twelve months as of March 31, 2013. Year Ended December 31, -------------------------------------------------------------------------------- EX-99.3 4 q120138-kex993.htm EX 99.3 - PREPARED REMARKS Q1 2013 8-K EX99.3 Exhibit 99.3 [[Image Removed]] Q1 2013 Earnings Prepared Comments Jon Puckett, Celanese Corporation, Vice President, Investor Relations Welcome to the Celanese Corporation first quarter 2013 financial results recording. The date of this recording is April 18, 2013. Please note that no portion of this presentation may be rebroadcast or reproduced in any form without the prior written consent of Celanese. My name is Jon Puckett. I am the Vice President of Investor Relations. Today you will be hearing from Mark Rohr, Chairman and Chief Executive Officer of Celanese, and Steven Sterin, Senior Vice President and Chief Financial Officer. The Celanese Corporation first quarter 2013 earnings release was distributed via business wire this afternoon and posted on our website, www.celanese.com, in the Investor section. The slides referenced during this recording are also posted on our website. Both items were submitted to the SEC in a current report on Form 8-K. As a reminder, some of the matters discussed today and included in our presentations may include forward-looking statements concerning, for example, Celanese Corporation's future objectives and results. Please note the cautionary language contained in the posted slides. Also, some of the matters discussed and presented include references to non-GAAP financial measures. Explanations of these measures and reconciliations to the comparable GAAP measures are included in the posted slides and the press release, as applicable. Mark Rohr will comment on some recent reporting changes, review our consolidated first quarter results including segments, provide our outlook for the remainder of 2013 and comment on some longer-term strategic actions. Steven will then comment on cash flow, net debt, shareholder returns and tax rate. I'd now like to turn the call over to Mark. Mark Rohr, Celanese Corporation, Chairman of the Board of Directors and Chief Executive Officer Thanks, Jon, and welcome to everyone listening in today. Before we get into our results let me talk about a couple of changes we made this quarter that should increase the transparency and consistency in our quarterly results. First, as we announced a couple of weeks ago, we adopted mark-to-market accounting for pension plans. This accounting convention recognizes the gains and losses related to plan investments and interest rate changes in the year they 1 -------------------------------------------------------------------------------- occur, rather than amortizing them over future periods. This change should provide investors better insight into underlying business performance. During the first quarter, we received our first quarterly dividend from our Chinese Acetate Ventures and expect this cadence going forward rather than the annual dividends. This change better reflects the ongoing value this business represents and demonstrates the strategic nature of these ventures. This quarter we also made good progress on some of our long-term strategic activities. First, with regards to our planned methanol unit in Clear Lake, Texas, we completed our design and began ordering long lead-time equipment. Final cost estimates are consistent with initial reports and the project timeline is consistent with our objective of being operational by mid-2015. The permitting process is progressing well and we are confident in our ability to secure the environmental credits needed for the unit. We are also in the process of finalizing the structure and agreement with our potential partner. During the quarter we signed the Memorandum of Understanding with the Indonesian oil company, Pertamina. Under the MOU we intended to establish a joint venture with Celanese having a majority share. Celanese would also license our TCXฎ Technology to the venture. The goal of the MOU is to select the first production location, initiate project permitting, and negotiate coal supply and other industrial partner agreements. We expect to complete this phase of the MOU by the end of this year. I am also pleased to announce that the Nanjing ethanol unit is mechanically complete and our sales teams are actively working with our customers to commercialize industrial ethanol, and I want to thank our project and operations teams for the great progress they have made getting us to this point. But, we still have a lot of work ahead of us to complete the unit commissioning and begin ramping up the production leading to commercial sales by the third and fourth quarters of this year. As this unit ramps up, we will divert merchant acetic acid to feed the ethanol unit and in the process elevate industry acid capacity utilization. Now, let me cover our consolidated first quarter results and share highlights for each reporting segment. For the quarter we reported adjusted earnings per share of $1.14, including the Acetate dividend of $24 million. This represents a 44 percent year-over-year growth and 54 percent sequential growth on consistent revenue of $1.6 billion. Our [segment] income margin came in at 16.8 percent up both sequentially and year-over-year by more than 400 basis points. Margin expansion reflects good production and sales mix, variable pricing trends and strategic actions in Consumer Specialties, Advanced Engineered Materials and Acetyl Intermediates. 2 -------------------------------------------------------------------------------- I am really, really pleased with these results and our team's ability to deliver strong performance in the face of softer end-market demand in legacy markets and economies across the globe. On a GAAP basis, diluted EPS came in at $0.88 for the first quarter of 2013 compared to $1.21 in the prior year. Recall that the prior year GAAP number included some favorable tax items that are highlighted in the press release. Beyond tax, there were only minor differences between GAAP and non-GAAP - principally related to ceasing production at Spondon and the plant relocation in Germany. We generated good cash flow again this quarter reporting operating cash flow of $147 million and adjusted free cash flow of $64 million as we continue to invest in growth projects like ethanol. This quarter's results positions us for another strong year of free cash flow and enables us to pursue our growth initiatives and balanced capital deployment strategy. Now for the segments - Advanced Engineered Materials' first quarter segment income was $78 million, up 26 percent from $62 million in the fourth quarter. Segment margins were 23.7 percent, a 300 basis point increase sequentially. Increased auto end-market applications helped overcome the ongoing weakness in European auto builds, reported to be down 9 percent year-over-year. Product mix was also favorable this quarter driven by higher medical end-market applications. Raw materials, a slight sequential tailwind, were offset by lower affiliate earnings, primarily due to lower MTBE pricing in Ibn Sina. Our ability to drive earnings growth and margins in a challenging European market points to the growing diversity of our end-markets, the value we provide to our customers and the breadth of our applications technology. In Consumer Specialties, first quarter segment income was $108 million, that's $30 million or 38 percent higher than the fourth quarter's $78 million. First quarter results also include $24 million in cash dividends as we began receiving quarterly dividends from our China acetate ventures. If you exclude the dividend, segment margins would have been 28 percent or 70 basis points higher than the last quarter. Margin improvement this quarter was supported by great plant operating reliability and higher pricing which combined to more than offset higher sequential raw material costs. Margins also benefited from our actions to rationalize our production footprint. We ceased production at the Spondon plant, which lowered energy and operating costs for the segment. However, we do maintain the ability to return this facility to operating status, if needed, in the future. In Industrial Specialties, first quarter segment income of $16 million was up $10 million sequentially, and segment income margins increased to 5.6 percent, a 320 basis points improvement over the prior quarter. Volumes improved 14 percent sequentially on seasonal trends, mostly in Emulsions for the European and North American markets. Pricing was consistent from the fourth quarter to the first quarter in both 3 -------------------------------------------------------------------------------- Emulsions and EVA as raw materials were relatively stable. On the downside, poor photovoltaic demand continues to impact segment sales of some EVA products. In Acetyl Intermediates, first quarter segment income was $79 million, a 14 percent improvement over the fourth quarter. Segment margins increased to 9.8 percent, a 100 basis point sequential increase, driven by 5 percent higher volumes as demand for acetic acid and downstream derivative products improved quarter over quarter in North America and Asia outside of China. Demand in China was lower sequentially primarily due to the timing of Chinese New Year. System wide pricing declined about 1 percent while raw material costs were consistent from the fourth quarter to the first quarter. Stepping back from the details I am very proud of our teams hard work and accomplishments this quarter. Without it we wouldn't have gotten off to such a strong start. To grow in this environment requires our sales and technology teams to identify chemistry and applications that align with customer needs while also creating value for Celanese. Then rapidly get those opportunities commercialized. Along those lines as the results show we are having some success and let me give you a few examples. Our strength in polymer chemistry combined with our material engineering capability have resulted in a significant increase of Celanese applications on the highly anticipated redesign of GM's light duty truck platform. Giving us confidence in our ability to deliver growth in the auto segment despite challenging auto build numbers out of Europe. Our model in electronics follows a similar strategy combining the same expertise but at an entirely different pace. A pace needed to meet the short development cycles of this industry. For example, we are having really good success at one of the largest smartphone companies in the world. Our initial application was around the compact camera module on one of their existing platforms. Our success here has helped broadened our relationship and, as a result, we have expanded from one application on the current platform to a handful of applications on the new platform that will be rolling out this summer. Our expertise also provides us with opportunities to expand the relationship beyond the smartphone to other electronic devices in this technology company's portfolio. Successes like these are key to meeting our engineering materials growth expectations. On another front we made our first commercial sale of Nutrinova's taste solution. This concept of selling a formulated taste profile, tailored for each application is a new business model for Celanese and the artificial sweetener industry. We're excited about this model and the opportunity it brings to our customers and to us. Now let's turn to our outlook for the remainder of 2013. At a consolidated level, we expect continued economic uncertainty through the year. As a result our growth will be largely the result of Celanese- 4 -------------------------------------------------------------------------------- specific initiatives like productivity, our Acetate footprint rationalization, the expansion at our China acetate venture in Nantong and the start- up of ethanol production in Nanjing. As the earlier examples illustrate we also expect to drive growth by supporting our customer needs and developing unique applications that help them be successful. Over the last six months we have been spending much more time with our customers, myself included, and our initial success in working with them and our results this quarter give us confidence we can deliver on our objective of 12 to 14 percent adjusted earnings growth in 2013. With that, I'll now turn it over to Steven. Steven? Steven Sterin, Celanese Corporation, Senior Vice President and Chief Financial Officer Thanks, Mark. Given some of the moving parts this quarter I'd like to highlight a couple of items. Starting with the first quarter of last year, our original adjusted EPS was reported as $0.72 a share. When you add the Q1 2012 pension accounting adjustment of $0.07, you get $0.79 a share. Also, keep in mind that this quarter we began receiving our China acetate dividends quarterly which contributed $0.12 to this quarters results. In the first quarter of 2013 we generated adjusted EPS of $1.14. Our innovation success in Advanced Engineered Materials along with our broad end-market footprint offset lower European auto builds and drove significant growth in AEM. Our footprint rationalization plans in Acetate delivered expanded margins in Consumer Specialties. Our productivity programs helped us increase margins in Acetyl Intermediates. Now let me move into the details of cash flow, net debt, shareholder returns and our effective tax rate. Our cash flow results were good for a first quarter as we generated $147 million of operating cash flow and $64 million of adjusted free cash flow. When you compare cash flow between Q1 last year and Q1 this year, there are a couple of items I would like to bring to your attention. Last year in Q1, we had a reduction in working capital which is unusual for the first quarter, but was due to destocking seen then in Europe and Asia. Typically, first quarter working capital needs are the highest of all the quarters, which is consistent with Q1 2013 results. This working capital timing difference is about $165 million year-over-year. Also, Q1 2012 operating cash flow included a nonrecurring special cash dividend from one of our Asian affiliates of approximately $70 million. During Q1 2013, we received a $24 million quarterly dividend from our China acetate ventures and expect we will receive quarterly dividends going forward. Our cash flow results this quarter put us on a pace to continue to deliver strong cash flows. We have provided our expected cash outflows for the year on slide 15. 5 -------------------------------------------------------------------------------- Our solid cash flow results helped us increase the amount of cash we have our balance sheet and we ended the quarter with just under $1 billion of cash. We also reduced net debt to just below $2.1 billion as of March 31 which is the second lowest quarterly level in eight years. Our continued progress with net debt, net leverage ratios and interest coverage ratios makes us look more and more like an investment grade company than ever before, which is one of our objectives. We will continue to be opportunistic with regards to refinancing opportunities and debt reduction in the future to further improve our credit profile. We also expect to continue to return cash to shareholders through increased dividends and share repurchases. Over the last several years we have steadily increased our dividend at a CAGR north of 20%. We also have just under $400 million remaining on our share repurchase authorization and we will continue to offset dilution and be opportunistic in repurchasing shares. Let me spend a moment on taxes. The effective US GAAP tax rate for Q1 2013 was 35 percent for the quarter versus a benefit of 61 percent in the prior year quarter. The tax benefit in the first quarter of 2012 was primarily driven by the recognition of $142 million in benefits from foreign tax credits. The tax credits will be recognized as a benefit to our cash taxes over time. The tax rate for adjusted EPS in Q1 2013 was 19 percent, or 200 basis points higher than in 2012, mainly due to a higher proportion of our earnings being generated in the United States which has one of the highest statutory tax rates. We expect that our adjusted tax rate for 2013 will be consistent with the first quarter rate of around 19%. This concludes our prepared remarks and we look forward to discussing our results with you on our earnings call tomorrow morning. Thank you. 6